✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Winner Medical Co Ltd

Common Name
Winner Medical
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,642
Ticker
300888
Exchange
SHENZHEN STOCK EXCHANGE
Description
Winner Medical Co., Ltd. is a leading manufacturer and supplier of medical and healthcare products. The company specializes in the production of a wide range of medical disposables and wound-care solu...

Winner Medical's GHG Emissions Data Preview

In 2024, Winner Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Winner Medical has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Winner Medical’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2022, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=300888&reporting_period=2024"

Verified Sources Behind Winner Medical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Winner Medical’s data sources below and access millions more through our Disclosure Search.

a. Winner Medical's ESG Report 2024

Insights into Winner Medical's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Winner Medical amounted to 213,229.1 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Winner Medical increased by 30.09%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Winner Medical's Scope 1 Emissions Over Time

202220232024015 k30 k45 k60 ktCO2e-16%-13%
  • Total Scope 1
  • Year-over-Year Change

What are Winner Medical's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Winner Medical were 32,222.54 metric tons of CO₂ equivalent (tCO₂e).a

Has Winner Medical reduced its Scope 1 emissions over time?

Since 2022, Winner Medical's Scope 1 emissions have decreased by 27.38%, reflecting a declining long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2023), Winner Medical's Scope 1 emissions decreased by 13.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Winner Medical's Scope 2 emissions?

In 2024, Winner Medical reported Scope 2 greenhouse gas (GHG) emissions of 181,006.56 tCO₂e without specifying the calculation method.a

Has Winner Medical reduced its Scope 2 emissions over time?

Since 2022, Winner Medical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 28.41%, reflecting a rising long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2023), Winner Medical's Scope 2 emissions (Unspecified Calculation Method) rose by 42.84% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Winner Medical use for Scope 2 reporting?

In 2024, Winner Medical reported its Scope 2 emissions using an unspecified methodology.a

Winner Medical's Scope 2 Emissions Over Time

202220232024050 k100 k150 k200 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Winner Medical's Value Chain Emissions

In 2024, Winner Medical reported 1,014,392.14 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Winner Medical includes a breakdown across 12 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chaina

Winner Medical's Scope 3 Emissions Over Time

20240300 k600 k900 k1.2 MtCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Winner Medical's Scope 3 emissions?

In 2024, Winner Medical reported total Scope 3 emissions of 1,014,392.14 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 90.73% of these emissions originated from upstream activities such as purchased goods and capital goods, while 9.27% came from downstream activities like product use, distribution, and end-of-life treatment.a

What categories of Scope 3 emissions does Winner Medical disclose?

In 2024, Winner Medical reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Winner Medical's Scope 3 emissions?

In 2024, the largest contributors to Winner Medical's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 672,440.55 tCO₂e (66.3%)
  • Upstream Transportation and Distribution (Cat. 4): 113,003.284 tCO₂e (11.14%)
  • End-of-Life Treatment of Sold Products (Cat. 12): 86,223.332 tCO₂e (8.5%)

Winner Medical's Scope 3 Emissions by Categories

UpstreamTransportation andDistribution(Cat. 4)(11.1%)End-of-LifeTreatment of SoldProducts (Cat. 12)(8.5%)Purchased Goods andServices (Cat. 1)(66.3%)

Insights into Winner Medical’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Winner Medical reported Scope 1 greenhouse gas (GHG) emissions of 32,222.54 tCO₂e and total revenues of USD 1,230 millions. This translates into an emissions intensity of 26.19 tCO₂e per millions USD.a

Winner Medical's Scope 1 Emissions Intensity Compared to Peers

52005,000200,00010,000,000Scope 1 Emissions (tCO2e)2501,00020,000200,000Revenues (Millions of USD)CSPYIADDWSnibeYear: 2023Scope 1: 210 tCO2eRevenue: $M 553Scope 1 Intensity: 0.38 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MHangzhou Tigermed ConsultingYear: 2024Scope 1: 210 tCO2eRevenue: $M 905Scope 1 Intensity: 0.23 tCO2e/$MCCCR MedicalYear: 2023Scope 1: 1,359 tCO2eRevenue: $M 1,556Scope 1 Intensity: 0.87 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 7,404Scope 1 Intensity: 0.43 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MSSSinopharm GroupYear: 2024Scope 1: 48,786 tCO2eRevenue: $M 87,180Scope 1 Intensity: 0.56 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MKangji Medical HoldingsYear: 2023Scope 1: 164 tCO2eRevenue: $M 143Scope 1 Intensity: 1.15 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYYYifeng Pharmacy ChainYear: 2024Scope 1: 1,082 tCO2eRevenue: $M 3,297Scope 1 Intensity: 0.33 tCO2e/$MIIImeik Technology DevelopmentYear: 2024Scope 1: 1,252 tCO2eRevenue: $M 415Scope 1 Intensity: 3.02 tCO2e/$MAAApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MWeigao GroupYear: 2024Scope 1: 3,096 tCO2eRevenue: $M 1,952Scope 1 Intensity: 1.59 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MAngelalign TechnologyYear: 2023Scope 1: 8 tCO2eRevenue: $M 229Scope 1 Intensity: 0.03 tCO2e/$MWWWinner MedicalYear: 2024Scope 1: 32,223 tCO2eRevenue: $M 1,230Scope 1 Intensity: 26.19 tCO2e/$M

How does Winner Medical's GHG emissions intensity compare to its peers?

In 2024, Winner Medical reported a Scope 1 emissions intensity of 26.19 tCO₂e per millions USD. Compared to the peer group median of 5.01, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Winner Medical rank on GHG emissions intensity within its industry?

In 2024, Winner Medical ranked 20 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Winner Medical among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into Winner Medical's Total Carbon Footprint

In 2024, Winner Medical reported a total carbon footprint of 1,227,621.24 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 648.99% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Winner Medical's total carbon footprint was Scope 3 emissions, accounting for 82.63% of the company's total carbon footprint, followed by Scope 2 emissions at 14.74%.a

Want Full Access to Winner Medical's GHG Emissions Dataset?
Start 30-Day Free Trial